The CXCR4 and adhesion molecule expression of CD34+ hematopoietic cells mobilized by “on-demand” addition of plerixafor to granulocyte–colony-stimulating factor

相似書籍

• Plerixafor (AMD3100) and granulocyte colony-stimulating factor (G-CSF) mobilize different CD34(+) cell populations based on global gene and microRNA expression signatures
  由: Donahue, Robert E., et al.
  出版: (2009)
• Early measurement of CD34+ cells in peripheral blood after cyclophosphamide and granulocyte colony-stimulating factor treatment predicts later CD34+ mobilisation failure and is a possible criterion for guiding “on demand” use of plerixafor
  由: Milone, Giuseppe, et al.
  出版: (2013)
• Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery
  由: Green, Michael M. B., et al.
  出版: (2016)
• Hematopoietic Stem Cell Mobilization for Gene Therapy: Superior Mobilization by the Combination of Granulocyte–Colony Stimulating Factor Plus Plerixafor in Patients with β-Thalassemia Major
  由: Yannaki, Evangelia, et al.
  出版: (2013)
• Biased action of the CXCR4-targeting drug plerixafor is essential for its superior hematopoietic stem cell mobilization
  由: Jørgensen, Astrid S., et al.
  出版: (2021)